Cellectar Biosciences, Inc. Convertible Debt, Noncurrent
Cellectar Biosciences, Inc. (CLRB) had Convertible Debt, Noncurrent of $3.80 million as of 2014-06-30, per its 10-Q filed 2014-08-04.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2014-08-04
- 2014-06-30: Convertible Debt, Noncurrent $3.80M.
- 2014-03-31: Convertible Debt, Noncurrent $3.77M.
- 2013-12-31: Convertible Debt, Noncurrent $0.00.
- 2010-12-31: Convertible Debt, Noncurrent $2.72M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2014-06-30 | $3.80M 10-Q · filed 2014-08-04 |
| 2014-03-31 | $3.77M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $0.00 10-Q · filed 2014-08-04 |
| 2010-12-31 | $2.72M 10-K · filed 2013-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |